Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oncolytic adenoviruses armed with heterologous genes

Oncolytic adenoviruses armed with heterologous genes

US Patent 11439678 · Granted Sep 13, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of glutamine synthetase for treating fatty liver disease2025
Use of glutamine synthetase for treating hyperammonemia2025
Dosing regime and formulations for type B adenoviruses2025
Use of glutamine synthetase for treating hyperammonemia2025
Adenovirus armed with bispecific T cell engager2025
Adenovirus armed with bispecific T cell engager2025
Oncolytic group B adenovirus expressing a stroma-targeted bispecific t-cell enga2024
Oncolytic group B adenovirus expressing a stroma-targeted bispecific t-cell enga2024
Group B adenovirus encoding an anti-TCR-complex antibody or fragment2024
Group B adenovirus encoding an anti-TCR-complex antibody or fragment2024
Oncolytic adenoviruses armed with heterologous genes2024
Oncolytic adenoviruses armed with heterologous genes2024